2BB score and signals
Relmada Therapeutics, Inc.’s current 2BB score is 15 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 7 | Very Low |
| Momentum | 54 | Stable |
| Financial strength | 30 | Weak |
| Quality | 40 | Normal |
| Risk | 58 | Moderate |
Company facts
| Headquarters | Coral Gables, Florida, United States |
| Founded | 2004 |
| Employees | 17 |
| 52-week range | $1.80 – $8.00 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2027-03-17 | — | -0.1607 | — | $0.00 |
| 2026-11-05 | — | -0.1479 | — | $0.00 |
| 2026-08-06 | — | -0.2035 | — | $0.00 |
| 2026-05-12 | -0.22 | -0.1989 | $0.00 | $0.00 |
Related companies
